Log in to save to my catalogue

Expression and processing of mature human frataxin after gene therapy in mice

Expression and processing of mature human frataxin after gene therapy in mice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_86223bf35bfc4a128468812ab0bc1d9b

Expression and processing of mature human frataxin after gene therapy in mice

About this item

Full title

Expression and processing of mature human frataxin after gene therapy in mice

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-04, Vol.14 (1), p.8391-8391, Article 8391

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Friedreich’s ataxia is a degenerative and progressive multisystem disorder caused by mutations in the highly conserved frataxin (FXN) gene that results in FXN protein deficiency and mitochondrial dysfunction. While gene therapy approaches are promising, consistent induction of therapeutic FXN protein expression that is sub-toxic has proven challeng...

Alternative Titles

Full title

Expression and processing of mature human frataxin after gene therapy in mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_86223bf35bfc4a128468812ab0bc1d9b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_86223bf35bfc4a128468812ab0bc1d9b

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-59060-0

How to access this item